journal article·2023-06Open access

Nanotechnology in the COVID-19 era: Carbon-based nanomaterials as a promising solution

Massimiliano Papi, Marco De Spirito, Valentina Palmieri

Carbon· Volume 210

Abstract

The Coronavirus Disease 2019 (COVID-19) pandemic has led to collaboration between nanotechnology scientists, industry stakeholders, and clinicians to develop solutions for diagnostics, prevention, and treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. Nanomaterials, including carbon-based materials (CBM) such as graphene and carbon nanotubes, have been studied for their potential in viral research. CBM unique effects on microorganisms, immune interaction, and sensitivity in diagnostics have made them a promising subject of SARS-CoV-2 research. This review discusses the interaction of CBM with SARS-CoV-2 and their applicability, including CBM physical and chemical properties, the known interactions between CBM and viral components, and the proposed prevention, treatment, and diagnostics uses.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Carbon and Quantum Dots Applications · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection10.1186/s12929-022-00853-8 ↗
2. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway10.1038/s41564-022-01143-7 ↗
3. Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation10.2217/nnm-2021-0004 ↗
4. A materials-science perspective on tackling COVID-1910.1038/s41578-020-00247-y ↗
5. Fabrication of air filters with advanced filtration performance for removal of viral aerosols and control the spread of COVID-1910.1016/j.cis.2022.102653 ↗
6. Carbon-based nanomaterials: promising antiviral agents to combat COVID-19 in the microbial-resistant era10.1021/acsnano.1c00629 ↗
7. Carbon-based nanomaterials for viral infection management10.1063/5.0032427 ↗
8. The future development of bacteria fighting medical devices: the role of graphene oxide10.1080/17434440.2016.1245612 ↗
9. The graphene oxide contradictory effects against human pathogens10.1088/1361-6528/aa6150 ↗
10. Quantitative protein corona composition and dynamics on carbon nanotubes in biological environments10.1002/anie.202008175 ↗
11. Graphene oxide touches blood: in vivo interactions of bio-coronated 2D materials10.1039/C8NH00318A ↗
12. Advances in carbon nanomaterials for immunotherapy
13. Can graphene take part in the fight against COVID-19?10.1016/j.nantod.2020.100883 ↗
14. Face masks and nanotechnology: keep the blue side up10.1016/j.nantod.2021.101077 ↗
15. Tools and techniques for severe Acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection10.1128/CMR.00228-20 ↗
16. SARS-CoV-2 virion physicochemical characteristics pertinent to abiotic substrate attachment10.1016/j.cocis.2021.101466 ↗
17. A novel coronavirus from patients with pneumonia in China
18. Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation
19. Population dynamics and structural effects at short and long range support the hypothesis of the selective advantage of the G614 SARS-CoV-2 spike variant10.1093/molbev/msaa337 ↗
20. OMICRON’S structure could help explain its global takeover10.1038/d41586-022-00292-3 ↗
21. The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein
22. Omicron: a shift in the biology of SARS-CoV-210.1038/s41564-022-01149-1 ↗
23. Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to delta variant of SARS-CoV-2 isolates10.1038/s41422-022-00619-9 ↗
24. The future development of bacteria fighting medical devices: the role of graphene oxide10.1080/17434440.2016.1245612 ↗
25. Shape dependent physical mutilation and lethal effects of silver nanoparticles on bacteria10.1038/s41598-017-18590-6 ↗
26. A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike
27. Single-particle characterization of SARS-CoV-2 isoelectric point and comparison to variants of interest10.3390/microorganisms9081606 ↗
28. Surface chemistry can unlock drivers of surface stability of SARS-CoV-2 in a variety of environmental conditions10.1016/j.chempr.2020.08.001 ↗
29. Varied-shaped gold nanoparticles with nanogram killing efficiency as potential antimicrobial surface coatings for the medical devices10.1038/s41598-021-91847-3 ↗
30. Form follows function: nanoparticle shape and its implications for nanomedicine10.1021/acs.chemrev.7b00194 ↗
31. Interactions of nanoparticles and biosystems: microenvironment of nanoparticles and biomolecules in nanomedicine10.3390/nano9101365 ↗
32. Recent advances in immunosafety and nanoinformatics of two-dimensional materials applied to nano-imaging10.3389/fimmu.2021.689519 ↗
33. Plasma protein corona reduces the haemolytic activity of graphene oxide nano and micro flakes10.1039/C5RA15083C ↗
34. Graphene surfaces interaction with proteins, bacteria, mammalian cells, and blood constituents: the impact of graphene platelet oxidation and thickness10.1021/acsami.9b21841 ↗
35. Complement activation and protein adsorption by carbon nanotubes10.1016/j.molimm.2005.02.006 ↗
36. Plasma protein corona forming upon fullerene nanocomplex: impact on both counterparts10.1016/j.partic.2022.04.006 ↗
37. The protein corona determines the cytotoxicity of nanodiamonds: implications of corona formation and its remodelling on nanodiamond applications in biomedical imaging and drug delivery10.1039/D0NA00231C ↗
38. Carbon nanomaterials for biological imaging and nanomedicinal therapy10.1021/acs.chemrev.5b00008 ↗
39. Carbon nanotube-A review on synthesis, properties and plethora of applications in the field of biomedical science10.1016/j.sintl.2020.100003 ↗
40. A concise review of carbon nanotube's toxicology10.3402/nano.v4i0.21521 ↗
41. A brief review of graphene-based biosensors developed for rapid detection of COVID-19 biomarkers10.3390/bios13030307 ↗
42. Quantum dot-conjugated SARS-CoV-2 spike pseudo-virions enable tracking of angiotensin converting enzyme 2 binding and endocytosis10.1021/acsnano.0c05975 ↗
43. High-throughput confocal imaging of quantum dot-conjugated SARS-CoV-2 spike trimers to track binding and endocytosis in HEK293T cells
44. A review of carbon nanomaterials' synthesis via the chemical vapor deposition (CVD) method10.3390/ma11050822 ↗
45. Application of carbon-based nanomaterials in sample preparation: a review10.1016/j.aca.2013.03.054 ↗
46. Carbon onions for electrochemical energy storage10.1039/C5TA08295A ↗
47. Biocompatibility study of electrospun nanocomposite membranes based on chitosan/polyvinyl alcohol/oxidized carbon nano-onions10.3390/molecules26164753 ↗
48. Functionalized carbon nano onion as a novel drug delivery system for brain targeting
49. Nanocone—versatile nanofiller for cutting-edge polymeric nanocomposite
50. Enhanced bioactivity of ZnO nanoparticles—an antimicrobial study10.1088/1468-6996/9/3/035004 ↗
51. Toxicity of graphene and graphene oxide nanowalls against bacteria10.1021/nn101390x ↗
52. Tailoring shape and size of biogenic silver nanoparticles to enhance antimicrobial efficacy against MDR bacteria10.1016/j.micpath.2016.11.012 ↗
53. Graphene nanoplatelet and graphene oxide functionalization of face mask materials inhibits infectivity of trapped SARS-CoV-210.1016/j.isci.2021.102788 ↗
54. Perspectives on mechanistic implications of ROS inducers for targeting viral infections10.1016/j.ejphar.2020.173621 ↗
55. Graphene oxide touches blood:: in vivo interactions of bio-coronated 2D materials10.1039/C8NH00318A ↗
56. Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide10.1021/nn202190c ↗
57. Effect of the graphene nanosheet on functions of the spike protein in open and closed states: comparison between SARS-CoV-2 wild type and the Omicron variant10.1021/acs.langmuir.2c02316 ↗
58. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion10.1038/s41586-020-2772-0 ↗
59. Exploring the role of triazole functionalized heteroatom Co-doped carbon quantum dots against human coronaviruses10.1016/j.nantod.2020.101001 ↗
60. Blocking SARS-CoV-2 delta variant (B. 1.617. 2) spike protein receptor-binding domain binding with the ACE2 receptor of the host cell and inhibiting virus infections using human host defense peptide-conjugated graphene quantum dots10.1021/acsomega.2c00113 ↗
61. Functional carbon quantum dots as medical countermeasures to human coronavirus10.1021/acsami.9b15032 ↗
62. Insights into the conformation changes of SARS-CoV-2 spike receptor-binding domain on graphene
63. Structural behavior of monomer of SARS-CoV-2 spike protein during initial stage of adsorption on graphene
64. Synthesis of exfoliated multilayer graphene and its putative interactions with SARS-CoV-2 virus investigated through computational studies10.1080/07391102.2020.1817788 ↗
65. Biomimetic antimicrobial cloak by graphene-oxide agar hydrogel10.1038/s41598-016-0010-7 ↗
66. Reduction and shaping of graphene-oxide by laser-printing for controlled bone tissue regeneration and bacterial killing10.1088/2053-1583/aa9ca7 ↗
67. Enhanced antibacterial activity through the controlled alignment of graphene oxide nanosheets10.1073/pnas.1710996114 ↗
68. Bactericidal vertically aligned graphene networks derived from renewable precursor10.1016/j.cartre.2022.100157 ↗
69. Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations10.1007/s13346-021-01054-w ↗
70. Lethal interactions of SARS-CoV-2 with graphene oxide: implications for COVID-19 treatment10.1021/acsanm.1c02446 ↗
71. Graphene oxide nanosheets interact and interfere with SARS‐CoV‐2 surface proteins and cell receptors to inhibit infectivity
72. Graphene sheets with defined dual functionalities for the strong SARS‐CoV‐2 interactions
73. In-silico modelling of fullerene and fullerene adsorbed by nO2 molecules (N (O2)@ Cm with N= 1, 2, 4 and M= 48 and 60) as potential SARS-CoV-2 inhibitors10.1007/s12034-021-02505-3 ↗
74. Carbon fullerene and nanotube are probable binders to multiple targets of SARS-CoV-2: insights from computational modeling and molecular dynamic simulation studies10.1016/j.meegid.2021.105155 ↗
75. Tracking the interaction between single-wall carbon nanotube and SARS-cov-2 spike glycoprotein: a molecular dynamics simulations study10.1016/j.compbiomed.2021.104692 ↗
76. Carbon nanotubes for rapid capturing of SARS-COV-2 virus: revealing a mechanistic aspect of binding based on computational studies10.1039/D0RA08888A ↗
77. Fluorescent nanodiamond-based spin-enhanced lateral flow immunoassay for detection of SARS-CoV-2 nucleocapsid protein and spike protein from different variants
78. The inactivation and destruction of viruses by reactive oxygen species generated through physical and cold atmospheric plasma techniques: current status and perspectives10.1016/j.jare.2022.03.002 ↗
79. 3D-Printed graphene polylactic acid devices resistant to SARS-CoV-2: sunlight-mediated sterilization of additive manufactured objects10.1016/j.carbon.2022.03.036 ↗
80. Highly efficient and rapid inactivation of coronavirus on non‐metal hydrophobic laser‐induced graphene in mild conditions
81. Superhydrophobic, photo-sterilize, and reusable mask based on graphene nanosheet-embedded carbon (GNEC) film
82. Reusable and recyclable graphene masks with outstanding superhydrophobic and photothermal performances10.1021/acsnano.0c02250 ↗
83. Toward nanotechnology-enabled approaches against the COVID-19 pandemic10.1021/acsnano.0c03697 ↗
84. Laser-mediated antibacterial effects of few-and multi-layer Ti3C2Tx MXenes10.1016/j.apsusc.2021.150795 ↗
85. Carbon-based materials for photodynamic therapy: a mini-review10.1007/s11705-018-1750-7 ↗
86. Nano antiviral photodynamic therapy: a probable biophysicochemical management modality in SARS-CoV-210.1080/17425247.2021.1829591 ↗
87. Materials and device design for advanced phototherapy systems
88. Photodynamic therapy with fullerenes in vivo: reality or a dream?10.2217/nnm.11.144 ↗
89. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
90. Application of photodynamic therapy in immune-related diseases10.1016/j.pdpdt.2021.102318 ↗
91. 3D graphene scaffolds for skeletal muscle regeneration: future perspectives10.3389/fbioe.2020.00383 ↗
92. Metabolic implications of oxidative stress and inflammatory process in SARS-CoV-2 pathogenesis: therapeutic potential of natural antioxidants10.3389/fcimb.2021.654813 ↗
93. Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials10.1016/S2666-5247(22)00390-1 ↗
94. Principles for optimization and validation of mRNA lipid nanoparticle vaccines against COVID-19 using 3D bioprinting10.1016/j.nantod.2022.101403 ↗
95. Applications of nanomaterials as vaccine adjuvants10.4161/hv.29589 ↗
96. Biological nanoparticles in vaccine development
97. Tuning the immune system by nanoparticle-biomolecular corona10.1039/D2NA00290F ↗
98. Cellular toxicity and immunological effects of carbon-based nanomaterials10.1186/s12989-019-0299-z ↗
99. Graphene, other carbon nanomaterials and the immune system: toward nanoimmunity-by-design10.1088/2515-7639/ab9317 ↗
100. Ultrasmall graphene oxide supported gold nanoparticles as adjuvants improve humoral and cellular immunity in mice10.1002/adfm.201401358 ↗